Company / Financials
Phibro Animal Health Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.3B
FY2025 · +27.4% YoY
Net Income
$48.3M
FY2025 · +1897.7% YoY
Profit Margin
3.7%
FY2025 · net income / revenue
ROE
16.9%
FY2025 · return on equity
Total Assets
$1.4B
FY2025
Total Debt
-
FY2025
Equity
$285.7M
FY2025
ROA
3.5%
FY2025 · return on assets
Statement paths
Metric history
Revenue HistoryTotal revenue from operations$1.3B+27.4% YoYNet Income HistoryProfit after all expenses and taxes$48.3M+1897.7% YoYGross Profit HistoryRevenue minus cost of goods sold$399.9M+27.7% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$896.3M+27.2% YoYOperating Income HistoryProfit from core business operations before interest and taxes$110.5M+107.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$289.5M+11.4% YoYR&D Expense HistoryResearch and development spending$23.7M-18.7% YoYInterest Expense HistoryCost of borrowing and debt obligations$13.7MIncome Tax HistoryTotal income tax expense$19.7M+132.1% YoYEPS (Basic) HistoryBasic earnings per share$0.81-33.1% YoY